At the time of writing, Repare Therapeutics Inc [RPTX] stock is trading at $1.32, up 10.92%. An important factor to consider is whether the stock is rising or falling in short-term value. The RPTX shares have gain 14.78% over the last week, with a monthly amount drifted -5.04%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Repare Therapeutics Inc [NASDAQ: RPTX] stock has seen the most recent analyst activity on June 09, 2023, when Stifel upgraded its rating to a Buy and also boosted its price target to $16 from $11. Previously, Morgan Stanley downgraded its rating to Equal-Weight on February 03, 2023, and dropped its price target to $15. On January 06, 2023, CapitalOne initiated with a Overweight rating and assigned a price target of $28 on the stock. Stifel downgraded its rating to a Hold but stick to its price target of $11 on April 12, 2022. Stifel started tracking with a Buy rating for this stock on September 23, 2021, and assigned it a price target of $48. In a note dated September 13, 2021, H.C. Wainwright initiated an Buy rating and provided a target price of $54 on this stock.
For the past year, the stock price of Repare Therapeutics Inc fluctuated between $1.10 and $8.49. Currently, Wall Street analysts expect the stock to reach $10 within the next 12 months. Repare Therapeutics Inc [NASDAQ: RPTX] shares were valued at $1.32 at the most recent close of the market. An investor can expect a potential return of 657.58% based on the average RPTX price forecast.
Analyzing the RPTX fundamentals
According to Repare Therapeutics Inc [NASDAQ:RPTX], the company’s sales were 66.52M for trailing twelve months, which represents an -100.00% plunge. Gross Profit Margin for this corporation currently stands at 0.98% with Operating Profit Margin at -1.4%, Pretax Profit Margin comes in at -1.23%, and Net Profit Margin reading is -1.26%. To continue investigating profitability, this company’s Return on Assets is posted at -0.41, Equity is -0.41 and Total Capital is -0.53. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.01.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.2231 points at the first support level, and at 1.1263 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.3684, and for the 2nd resistance point, it is at 1.4169.
Ratios To Look Out For
It is important to note that Repare Therapeutics Inc [NASDAQ:RPTX] has a current ratio of 6.45. On the other hand, the Quick Ratio is 6.45, and the Cash Ratio is 2.59. Considering the valuation of this stock, the price to sales ratio is 0.84, the price to book ratio is 0.32.
Transactions by insiders
Recent insider trading involved Segal Lloyd Mitchell, PRESIDENT AND CEO, that happened on Mar 28 ’24 when 2650.0 shares were sold. PRESIDENT AND CEO, Segal Lloyd Mitchell completed a deal on Apr 01 ’24 to sell 2491.0 shares. Meanwhile, EVP, CHIEF FINANCIAL OFFICER Forte Steve sold 825.0 shares on Mar 28 ’24.
